Embed code
Note: this content has been automatically generated.
thank you very much Christopher this
very very unclear and fascinating talk
with lots of thought-provoking
statements i'm sure there are many
questions are there any questions in the
audience i was telling us that
recognition is superior to to dopamine
yeah and then I probably mr. point that
then you tell us that we should use WT
mean why not
norepinephrine well I think you should
we can use both depending on the on the
situation where you're in when you have
higher vascular resistance then you you
first need something to improve
myocardial contractility and sometimes
you it makes sense to use both the rumen
to increase positive inotropic support
norepinephrine to try trait the vascular
resistance
I think that's individual clinical that
judgment according to the hammer dynamic
situation a certain hour of like the
baby actually usually newborn babies
usually am especially gram-negative that
they have high peripheral vascular
resistance and if I don't hug you into
the club open on the weekend often given
cope to question if these are allowed
first regarding this million of study
and was million monotherapy or was it
our combined with another drop
well as I as far as i remember well in
India enterovirus that was monotherapy
the Vietnam trial
yes and in there india dose-finding
studies it was always add onto usually
epinephrine
ok and the second question
got the food management in sepsis you
said that we should be very close with a
adeboye char fluids and Drita under
echocardiographic our control and
cartography control and what is your
suggestion for the bases are free that
we're giving should we reduce the mass
play also we need 250 per kilo
how do you do that the basic solution
you're going well I i wouldn't change
the basic solution we just keep it
running and then add extra fluid
according to what you see in the echo
and if we see already that our heart is
over loaded with food
well then you should have then you then
of course you should use an eye drop but
you should do you would do always look
at the acting out i hope i think that
because you from the outside it's
difficult to tell
okay thank you very much
let's define it want to add a word of
caution and to make sure that not
everybody goes home using intoxicated
the moment because you have to look at
the numbers in exasperation small it's
the small studies and most of them are
from Poland you showed an example where
very few small studies short and
positive effect and then there was a
large RC done and the effect is gone so
controlling to publication bias and I
think we need a large country a study
but I i think it's very difficult to do
such as such a trial because overall
acceptance which meets extended
hemodynamic support is a rare we talked
a lot about this but most babies don't
have severe sepsis they came they
receive antibiotics a little bit of
sodium chloride and that's fine
so the severe sepsis is a rare if you
look at the apple trials even they had
to have recruited many many centers and
every Center just had two or three cases
which they added to their to the trial
and such a try is very very expensive
because you have to initiate so many
centers and I don't think that ever
it's such a trial will be financed at
least in in the lodge light in in
northern North America or Europe just
too costly
thank you very much i think you're right

Share this talk: 


Conference program

Welcome Words
M. Roth-Kleiner, R. Arlettaz Mieth
10 jan. 2017 · 9:33 matin
Short Reports Introduction
E. Giannoni, T. Karen, Resp. Lausanne, Zürich
10 jan. 2017 · 9:38 matin
Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 jan. 2017 · 9:39 matin
Q&A - Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 jan. 2017 · 9:44 matin
Retinopathy of Prematurity
Roland Gerull, Bern
10 jan. 2017 · 9:47 matin
Q&A - Retinopathy of Prematurity
Roland Gerull, Bern
10 jan. 2017 · 9:54 matin
Parechovirus Infection: A Rare Cause of Neonatal Encephalitis (in French)
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 jan. 2017 · 9:59 matin
Q&A - Parechovirus Infection: A Rare Cause of Neonatal Encephalitis
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 jan. 2017 · 10:04 matin
Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 jan. 2017 · 10:17 matin
Q&A - Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 jan. 2017 · 10:25 matin
Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 jan. 2017 · 10:27 matin
Q&A - Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 jan. 2017 · 10:34 matin
Introduction to Christoph Berger's Presentation
C. Kind, R. Gerull, Resp. St.Gallen, Bern
10 jan. 2017 · 10:37 matin
Vertical Infections: An Update
Christoph Berger, Zürich
10 jan. 2017 · 10:40 matin
Q&A - Vertical Infections: An Update
Christoph Berger, Zürich
10 jan. 2017 · 11:15 matin
Introduction to Eric Giannoni's Presentation
R. Pfister, S. Kämpfen, Resp. Geneva, Basel
10 jan. 2017 · 11:44 matin
Sepsis, Antibiotics and Resistances: Where Are We?
Christoph Bührer, Berlin
10 jan. 2017 · 2:21 après-midi
Use and Abuse of Antibiotics in Neonatology
Martin Stocker, Lucerne
10 jan. 2017 · 2:50 après-midi
Panel Discussion : Controversies on Use of Antibiotics in Neonatology
Martin Stocker, Christoph Berger, Eric Giannoni, Christoph Bührer
10 jan. 2017 · 3:10 après-midi
Introduction to Christoph Bührer's Presentation
Romaine Arlettaz Mieth , Neonatologist, Zürich, President of the Organizing Committee
10 jan. 2017 · 3:47 après-midi
Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 jan. 2017 · 3:48 après-midi
Q&A - Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 jan. 2017 · 4:16 après-midi
SwissNeoDose Project
Marc Pfister, Ped Pharmacology, UKBB
10 jan. 2017 · 4:20 après-midi
Awards (Case of the Year; Milupa; Best Poster Case Report; Best Oral Short Presentation) & Closing Comments
Matthias Roth-Kleiner, CHUV, President of the SSN
10 jan. 2017 · 4:30 après-midi

Recommended talks

Introduction to the Geotextile Workshop
Daniele Cazzuffi, IGS Past President CESI SpA, Italy
8 avr. 2014 · 2:11 après-midi